The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of ovarian ablation or suppression on breast cancer recurrence and survival: Patient-level meta-analysis of 14,993 pre-menopausal women in 25 randomized trials.
 
Richard G. Gray
No Relationships to Disclose
 
Rosie Bradley
No Relationships to Disclose
 
Jeremy Braybrooke
No Relationships to Disclose
 
Mike Clarke
No Relationships to Disclose
 
Robert Kerrin Hills
No Relationships to Disclose
 
Richard Peto
No Relationships to Disclose
 
Jonas C. S. Bergh
No Relationships to Disclose
 
Sandra M. Swain
Leadership - Seagen
Stock and Other Ownership Interests - SEAGEN
Consulting or Advisory Role - AstraZeneca; Athenex; Aventis Pharma; bioTheranostics; Daiichi Sankyo; Exact Sciences; Genentech/Roche; Jaguar Health; Lilly; Merck; Molecular Templates; Napo Pharmaceuticals; Natera
Research Funding - Genentech (Inst); Kailos Genetics (Inst)
Travel, Accommodations, Expenses - Aventis Pharma; Daichi Sankyo
Other Relationship - AstraZeneca; AstraZeneca; Roche
(OPTIONAL) Uncompensated Relationships - Genentech/Roche
 
Nancy E. Davidson
No Relationships to Disclose
 
Prudence A. Francis
No Relationships to Disclose
 
Meredith M. Regan
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group (Inst); Ipsen (Inst); Tersera; Tolmar
Research Funding - AstraZeneca (Inst); Bayer (Inst); bioTheranostics (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); TerSera (Inst)